novo nordisk compounded semaglutide medicines containing Novo Nordisk finds compounded Wegovy

These cover obesity, type 2 diabetes, heart disease, knee arthritis, and liver disease (Giblin et al., DOM 2026)

The LLNA: A brief review of recent advances and limitations

Tang added that diet and exercise alone often fall short of addressing symptoms: "A lot of people can exercise very aggressively and regularly or watch what they eat and still struggle with hormone imbalances, weight, and blood sugar." That was the case for Haley Sipes, a 31-year-old mother of three based in Western Kentucky who experienced PCOS symptoms for years without a diagnosis

Semaglutide-treated mice lost 22% of their body weight, with fat mass dropping 46% and LBM dropping only about 4%

Not yet as an approved therapy

The table below covers the most clinically relevant interactions